Skip to main content
Log in

First Polynuclear Palladium Compounds [(C5H12NO)(PdCl3)]n and [(C10H16NO)2(Pd2Cl6)] with High Antitumor and Radioprotective Activity

  • Published:
Russian Journal of Coordination Chemistry Aims and scope Submit manuscript

Abstract

Polymeric palladium complexes [(C5H12NO)(PdCl3)]n (I) and [(C10H16NO)2(Pd2Cl6)] (II) were synthesized for the first time and studied by X-ray diffraction. Complexes I and II were found to have moderate toxicity (3rd class of toxicity) and high antitumor and radioprotective activities. Treatment of Lewis lung carcinoma (LLC) with I and II induced statistically significant antitumor and antimetastatic effects exceeding those of cisplatin: the use of I and II retarded the growth of LLC by 60.0%, while cisplatin retarded it by 48.0%. The decrease in the LLC metastasis was 75% upon the action of I, 91.0% in the case of II, and 69.0% for cisplatin. It was shown that II has a clear-cut radioprotective action. On single exposure of mice to a dose of 8.2 Gy, their survival rate was 58.0% versus 4.5% for the control. Fractional exposure to increasing doses (2.5, 3, and 3.5 Gy) resulted in 75.0% survival rate versus 33.0% for the control.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1.
Fig. 2.
Fig. 3.
Fig. 4.
Fig. 5.

Similar content being viewed by others

REFERENCES

  1. Lippert, B., Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug, Weinheim: Wiley-VCH, 1995.

    Google Scholar 

  2. Fulford, A., Plat. Met. Rev., 1966, vol. 40, no. 4, p. 161.

    Google Scholar 

  3. Giachetti, S., Perpoint, B., Zidani, R., et al., J. Clin. Oncol., 2000, vol. 18, p. 136.

    Article  Google Scholar 

  4. Weiss, R.V. and Poster, D.S., Cancer Treat. Rev., 1982, vol. 9, p. 37.

    Article  CAS  Google Scholar 

  5. Groth, S., Nielsen, H., Sorensen, J., et al., Cancer Chemother. Pharmacol., 1986, vol. 17, p. 191.

    Article  CAS  Google Scholar 

  6. Petrov, V.I., Fisenko, V.P., Arzamatsev, E.V., et al., Guide on Experimental (Pre-Clinical) Study of New Substances for Pharmacology, Remedium, 2000, p. 398.

    Google Scholar 

  7. Brienza, S., Vignoud, J., Itznaki, M., et al., Proc. Am. Soc. Clin. Oncol., 1995, vol. 14, p. 209.

    Google Scholar 

  8. Dress, M., Dengler, W.M., Hendrics, H.R., et al., Eur. J. Cancer. A, 1995, vol. 31, p. 356.

    Article  Google Scholar 

  9. Levi, F., Perpoint, B., Garuit, C., et al., Eur. J. Cancer, Part A, 1993, vol. 29, p. 1608.

    Google Scholar 

  10. Efimenko, I.A., Koord. Khim., 1998, vol. 24, no. 4, p. 282.

    Google Scholar 

  11. Zakharova (Efimenko), I.A., Issledovaniya po neorganicheskoi khimii i khimicheskoi tekhnologii (Studies in Inorganic Chemistry and Chemical Engineering), Moscow: Nauka, 1988, p. 171.

  12. Efimenko, I.A. and Shishilov, O.N., Russ. J. Inorg. Chem., 2012, vol. 57, no. 14, p. 1695. https://doi.org/10.1134/S0036023612140021

    Article  CAS  Google Scholar 

  13. Efimenko, I.A., Churakov, A.V., Ivanova, N.A., et al., Russ. J. Inorg. Chem., 2017, vol. 62, p. 1469. https://doi.org/10.1134/S0036023617110043

    Article  CAS  Google Scholar 

  14. Efimenko, I.A., Shishilov, O.N., Ivanova, N.A., et al., Precious Met., 2012, vol. 33, p. 240.

    Google Scholar 

  15. Zakharova, I.A., Zhavoronkov, N.M., Kurbanov, T.Kh., et al., USSR Inventor’s Certificate no. 1412229, 1988.

  16. Efimenko, I.A., Kurbakova, A.P., Grap, S.R. et al., RF Patent 2022968, Byull. Izobret., 1994, no. 21.

  17. Efimenko, I.A., Lokshin, B.V., and Ivanova, N.A., RF Patent 2089186, Byull. Izobret., 1997, no. 25.

  18. Efimenko, I.A. and Ivanova, N.A., Eurasian Patent no. 010431, Byull. Izobret., 2008, no. 4.

  19. Kuznetsov, N.T., Efimenko, I.A., Ivanova, N.A. et al., RF Patent 2613305, Byull. Izobret., 2017, no. 8.

  20. Tikhomirov, A.G., Ivanova, N.A., Erofeeva, O.S., et al., Russ. J. Coord. Chem., 2003, vol. 29, no. 7, p. 489. https://doi.org/10.1023/A:1024731014000

    Article  CAS  Google Scholar 

  21. Akat’eva, M.E., Erofeeva, O.S., Dobrynina, N.A., et al., Russ. J. Coord. Chem., 2004, vol. 30, no. 8, p. 584. https://doi.org/10.1023/B:RUCO.0000037439.30356.e0

    Article  Google Scholar 

  22. Gorbacheva, L.B., Tikhomirov, A.G., and Dederer, L.Yu., Khim.-Farm. Zh., 2008, vol. 42, no. 2, p. 3.

  23. Grekhova, A.K., Gorbacheva, L.B., and Ivanova, N.A., Biomed. Khim., 2013, vol. 59, no. 1, p. 107.

    Article  CAS  Google Scholar 

  24. Shishilov, O.N., Stromnova, T.A., Churakov, A.V., et al., Russ. J. Inorg. Chem., 2006, vol. 51, p. 574. https://doi.org/10.1134/S0036023606040127

    Article  Google Scholar 

  25. Qi-Pin Qin, Bi-Qun Zou, Ming-Xiong Tan, et al., Inorg. Chem. Commun., 2018, vol. 96, p. 106.

    Article  CAS  Google Scholar 

  26. Efimenko, I.A., Churakov, A.V., Erofeeva, O.S., et al., Russ. J. Coord. Chem., 2019, vol. 45, no. 9, p. 615. https://doi.org/10.1134/S1070328419090033

    Article  CAS  Google Scholar 

  27. Sheldrick, G.M., SADABS. Program for Scaling and Correction of Area Detector Data, Göttingen: Univ. of Göttingen, 1997.

    Google Scholar 

  28. Sheldrick, G.M., Acta Crystallogr., Sect. A: Found. Crystallogr., 2008, vol. 64, no. 1, p. 112.

    Article  CAS  Google Scholar 

  29. Kawano, K., Hattori, Y., Iwakura, H., et al., Exp. Ther. Med., 2012, vol. 4, no. 1, p. 61.

    Article  Google Scholar 

  30. Rukovodstvo po provedeniyu doklinicheskikh issledovanii lekarstvennykh sredstv (Guidelines for Preclinical Studies of Medicinal Agents), Part 1. Moscow: GrifiK, 2012.

  31. Groom, C.R. and Allen, F.H., Angew. Chem., Int. Ed. Engl., 2014, vol. 53, p. 662.

    Article  CAS  Google Scholar 

  32. Raper, E.S., Kubiak, M., and Glowiak, T., Acta Crystallogr., Sect. C: Cryst. Struct. Commun., 1997, vol. 53, p. 1201.

    Article  Google Scholar 

  33. Vranec, P., Potocnak, I., and Repovsky, P., Acta Crystallogr., Sect. C: Cryst. Struct. Commun., 2012, vol. 68, p. M370.

    Article  CAS  Google Scholar 

  34. Berezovskaya, I.V. Toksikologicheskii vestnik, 2010, no. 5, p. 1041.

  35. Radiatsionnaya meditsina (Radiation Medicine), Il’in, L.A., Ed., Moscow, 2004, vol. 1.

  36. Barchukov, V.G., Efimenko, I.A., Erofeeva, O.S., et al., RF Patent, 2699809, Byull. Izobret., 2019, no. 26.

Download references

ACKNOWLEDGMENTS

The X-ray diffraction study of compound I was performed using equipment of the Center for Collective Use, Kurnakov Institute of General and Inorganic Chemistry, Russian Academy of Sciences, within the state assignment. The X-ray diffraction data for II were collected at the Department of Chemistry, Durham University (UK).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. A. Efimenko.

Ethics declarations

The authors declare that they have no conflicts of int-erest.

Additional information

Translated by Z. Svitanko

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Efimenko, I.A., Filimonova, M.V., Churakov, A.V. et al. First Polynuclear Palladium Compounds [(C5H12NO)(PdCl3)]n and [(C10H16NO)2(Pd2Cl6)] with High Antitumor and Radioprotective Activity. Russ J Coord Chem 46, 339–349 (2020). https://doi.org/10.1134/S1070328420040028

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1134/S1070328420040028

Keywords:

Navigation